{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:40:18Z","timestamp":1792784418035,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Immune Design"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.vaccine.2020.08.003","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T23:14:01Z","timestamp":1597878841000},"page":"6367-6373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["ZVex\u2122, a dendritic-cell-tropic lentivector, primes protective antitumor T cell responses that are significantly boosted using heterologous vaccine modalities"],"prefix":"10.1016","volume":"38","author":[{"given":"Jardin A.","family":"Leleux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina C.","family":"Albershardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea J.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"ter Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.08.003_b0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","article-title":"Heterologous prime\u2013boost vaccination","volume":"21","author":"Lu","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2020.08.003_b0010","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1462-5822.2011.01594.x","article-title":"Immunologic considerations for generating memory CD8 T cells through vaccination: Vaccine-induced memory CD8 T cells","volume":"13","author":"Butler","year":"2011","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2020.08.003_b0015","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.168.9.4455","article-title":"Generation of CD8 + T Cell memory in response to low, high, and excessive levels of epitope","volume":"168","author":"Wherry","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.08.003_b0020","article-title":"On the role of dendritic cells versus other cells in inducing protective CD8+ T cell responses","author":"Zinkernagel","year":"20145","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.08.003_b0025","article-title":"First-in-human treatment with a dendritic cell-targeting lentiviral vector-expressing NY-ESO-1, LV305, induces deep, durable response in refractory metastatic synovial sarcoma patient","author":"Pollack","year":"20171","journal-title":"J Immunother"},{"key":"10.1016\/j.vaccine.2020.08.003_b0030","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1158\/1078-0432.CCR-19-1025","article-title":"First-in-class, first-in-human study evaluating LV305, a dendritic-cell tropic lentiviral vector, in sarcoma and other solid tumors expressing NY-ESO-1","volume":"25","author":"Somaiah","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.vaccine.2020.08.003_b0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/CJI.0000000000000067","article-title":"Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy","volume":"38","author":"Odegard","year":"2015","journal-title":"J Immunother"},{"key":"10.1016\/j.vaccine.2020.08.003_b0040","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1038\/mto.2016.10","article-title":"LV305, a dendritic cell-targeting integration-deficient ZVex TM -based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response","volume":"3","author":"Albershardt","year":"2016","journal-title":"Mol Ther - Oncolytics"},{"key":"10.1016\/j.vaccine.2020.08.003_b0045","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1016\/j.vaccine.2007.09.038","article-title":"Development and preclinical evaluation of an alphavirus replicon vaccine for influenza","volume":"25","author":"Hubby","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.003_b0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-065X.2010.00967.x","article-title":"Immunization delivered by lentiviral vectors for cancer and infectious diseases: Lentiviral vectors for cancer and infectious diseases","volume":"239","author":"Hu","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2020.08.003_b0055","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.vaccine.2020.08.003_b0060","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ymthe.2016.12.004","article-title":"HIV-1 Conserved mosaics delivered by regimens with integration-deficient DC-targeting lentiviral vector induce robust T cells","volume":"25","author":"Wee","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2020.08.003_b0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.it.2003.11.009","article-title":"Jump-starting the immune system: prime\u2013boosting comes of age","volume":"25","author":"Woodland","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2020.08.003_b0070","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.4049\/jimmunol.1502672","article-title":"Prime-boost immunization eliminates metastatic colorectal cancer by producing high-avidity effector CD8 + T cells","volume":"198","author":"Xiang","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.08.003_b0075","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.it.2006.09.004","article-title":"T cell memory and protective immunity by vaccination: is more better?","volume":"27","author":"Zanetti","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2020.08.003_b0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.immuni.2013.07.003","article-title":"Preexisting high frequencies of Memory CD8+ T cells favor rapid memory differentiation and preservation of proliferative potential upon boosting","volume":"39","author":"Fraser","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2020.08.003_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.01.025","article-title":"Persistence of integrase-deficient lentiviral vectors correlates with the induction of STING-independent CD8+ T cell responses","volume":"26","author":"Cousin","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2020.08.003_b0090","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ymthe.2016.11.001","article-title":"Dendritic cells cross-present immunogenic lentivector-encoded antigen from transduced cells to prime functional T cell immunity","volume":"25","author":"Hotblack","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2020.08.003_b0095","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1257","article-title":"Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination","volume":"11","author":"Badovinac","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2020.08.003_b0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ymthe.2006.02.015","article-title":"Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication","volume":"14","author":"Huarte","year":"2006","journal-title":"Mol Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20310239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20310239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:46:31Z","timestamp":1759401991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20310239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":20,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0264410X20310239"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ZVex\u2122, a dendritic-cell-tropic lentivector, primes protective antitumor T cell responses that are significantly boosted using heterologous vaccine modalities","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}